FDA Drug Recalls

Recalls / Class II

Class IID-0500-2023

Product

Rosuvastatin 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-3519-00

Affected lot / code info
Lot#: J0668398-121422, Exp. Date 12/31/2023; J0661225-111522, J0654053-101822 Exp. Date 11/30/2023; J0646383-091422, Exp. Date 09/30/2023

Why it was recalled

cGMP Deviations

Recalling firm

Firm
RemedyRepack Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
625 Kolter Dr Ste 4, Indiana, Pennsylvania 15701-3571

Distribution

Quantity
132 bottles
Distribution pattern
RemedyRepack distributed product to consignees nationwide within the United States

Timeline

Recall initiated
2023-03-20
FDA classified
2023-03-31
Posted by FDA
2023-04-12
Terminated
2023-10-19
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0500-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls